Newsbot

Brille verlegt? Kein Problem – Google organisiert den Alltag neu

Bei Googles Entwicklerkonferenz werden zukünftige Anwendungen für die Nutzer vorgestellt. Die Fortschritte auf diesem Gebiet sind gewaltig. Andere Projekte fallen zurück. Besonders ein Tool des Smartphones wird künftig noch wichtiger.

Balance of Power 05/14/24

"Balance of Power" focuses on the intersection of politics and global business. On the show today, Nick Akerman, Former Assistant US Attorney and Former Watergate Prosecutor, shares his insight on if the appearance of Speaker Mike Johnson, Governor Doug Burgum, and other Republicans attending former President Trumps court hearing calls for a judge to remove them due to potentially intimidating witnesses. Anna Ashton, Former Department of Defense Intelligence Officer & Founder of Ashton Analytic...

Discovery Reports First Quarter 2024 Financial Results

TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) today announced financial results for the three months ended March 31, 2024 (“Q1 2024”). The Company also provided a summary of key events since the beginning of 2024, including the release on February 20, 2024, of the feasibility study results (the “Feasibility Study” or “Study”) for Discovery’s 100%-owned Cordero silver project (“Cordero” or the “Project”) in Chihuahua Sta...

ispace EUROPE und CDS unterzeichnen Nutzlastservice-Vereinbarung für den Transport von Technologie für die genaue Bestimmung des Standortes auf dem Mond

LUXEMBURG--(BUSINESS WIRE)--ispace EUROPE S.A. (ispace-EUROPE), die in Luxemburg ansässige Tochtergesellschaft von ispace, inc. und Control Data Systems SRL (CDS) haben eine Nutzlastservice-Vereinbarung über den Transport von Messgeräten für die präzise Bestimmung des Standorts auf den Mond abgeschlossen. Dies teilten beide Unternehmen mit. CDS’s Technologie, die Präzisionslokalisierung mit Telekommunikation verbindet, nutzt Ultra-Breitband für die präzise Bestimmung von Positionen. Sie wurde s

Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status

TOKYO and CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that Eisai has initiated the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (U.S. brand name: LEQEMBI®) subcutaneous autoinjector for weekly maintenance d...

Five Things You Need to Know to Start Your Day: Asia

Good morning. China blasts America’s latest tariff move, the Fed Chair urges patience and Goldman’s John Waldron has a warning. Here’s what’s moving markets. — Isabelle Lee

Eisai initiates rolling Biologics License Application to US FDA for Leqembi® (lecanemab-irmb) for subcutaneous maintenance dosing

Stockholm, Sweden, May 15, 2024 – BioArctic ABs (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that they have initiated the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (U.S. brand name: Leqembi) subcutaneous autoinjector for weekly maintenance dosing after it was granted Fast Track designation by the FDA. In the US, Leqembi is indicated for the treatment of Alzheimer’s disease (AD) in patients wit...

Highs Before Key CPI Tomorrow | Bloomberg Markets: The Close 5/14/2024

Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Todays guests are Pictet Group, Maria Vassalou, US Trade Representative, Katherine Tai, On Holding, Hoffmann and Marc Maurer, Golden State Valkyries President, Jess Smith, Goldman Sachs President & COO, John Waldron. (Source: Bloomberg)

ROSEN, A RESPECTED AND LEADING FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CO, CORBF

NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF) between June 4, 2019 and May 3, 2022, both dates inclusive (the “Class Period”), of the important June 24, 2024 lead plaintiff deadline.